Address
455 North Bernardo Avenue
Mountain View, CA 94043
United States of America (the)
Phone
650 237 2700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
184
First IPO Date
April 22, 2021
| Name | Title | Pay | Year Born |
| Joel D. Becker | Chief Executive Officer, President & Director | 1.12M | 1968 |
| Rebecca L. Kuhn | Advisor | 588,399 | 1961 |
| Patrick F. Williams | Chief Financial Officer | 689,414 | 1973 |
| Martha J. Morrell | Chief Medical Officer | 725,315 | 1957 |
| Scott R. Schaper | Head of Investor Relations | 0 | N/A |
| Chris Reese | Senior Vice President of Sales | 0 | N/A |
| Dylan John | Chief of Operations & Development | 0 | N/A |
| Amy Treadwell | Vice President of Human Resources | 0 | N/A |
| Katie Keller | Vice President of Marketing | 0 | N/A |
| Leah Akin | General Counsel & Corporate Secretary | 0 | N/A |
NeuroPace, Inc. is a U.S.-based medical technology firm. It specializes in the creation and distribution of the RNS system, an advanced brain-responsive neuromodulation device designed to manage medically intractable focal epilepsy. This innovative system delivers tailored, real-time therapy directly to the source of seizures. Furthermore, the RNS system continuously records brain activity, providing medical professionals with the capability to monitor patients both on-site and remotely. The company supplies its devices to hospitals for both initial surgical implantations and subsequent replacement procedures. NeuroPace, Inc. was founded in 1997 and maintains its corporate headquarters in Mountain View, California.